埃沃迪胺通过调节FAK/STAT3/AKT信号通路来抑制肺癌的进展
Wen-Xin Yuan1, Wen Chen2,3,4, Ping Hu2,5
1Department of Ultrasonography, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, China.
The American journal of Chinese medicine
|June 29, 2025
概括
埃沃胺是一种天然化合物,有效地抑制肺癌细胞的生长和迁移. 它通过准关键信号通路而起作用,显示出作为非小细胞肺癌 (NSCLC) 的潜在治疗方法的希望.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 肺癌对全球健康构成重大挑战.
- 埃沃迪胺是一种来自*Tetradium ruticarpum*的化物,具有抗瘤特性.
- 埃沃胺对肺癌的确切作用机制尚未完全理解.
研究的目的:
- 为了研究埃沃胺对肺癌细胞的影响.
- 阐明埃沃胺抗癌活性的潜在分子机制.
- 在临床前肺癌模型中评估埃沃胺的疗效.
主要方法:
- 使用A549和H1299肺癌细胞系进行细胞增殖和迁移测定.
- 西部斑点分析用于评估蛋白质表达和酸化水平 (FAK,STAT3,AKT,CyclinA2,CyclinB1).
- 使用小鼠皮下瘤模型的体内研究.
主要成果:
- 埃沃迪胺显著抑制了A549和H1299细胞的增殖和迁移.
- 埃沃迪胺降低了化FAK,STAT3和AKT的调节,并降低了CyclinA2/B1的表达.
- 埃沃迪胺抑制了EGF诱导的FAK/STAT3/AKT酸化,并在体内减缓了瘤的生长.
结论:
- 埃沃胺抑制非小细胞肺癌 (NSCLC) 细胞的增殖和迁移.
- 该机制涉及EGF介导的FAK/STAT3/AKT路径的下调.
- 埃沃胺显示出作为NSCLC治疗剂的潜力.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
MAPK Signaling Cascades
6.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.2K


